Zystor
Milwaukee
About Zystor
ZyStor Therapeutics, Inc. is a privately-held biotechnology company developing enzyme replacement therapies for the treatment of lysosomal storage diseases.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1,001 – 5,000
- Total funding: $8.5M
- Funding stage: M&A
- Last round: Series A (Dec 2004)
- Website: zystor.com
- Phone: 414-727-9777
Industries & Categories
Biotechnology, Health Care, Therapeutics
Canonical: https://fsome.com/organization/zystor-3311921 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.